丹麦乳腺癌放疗后缺血性心脏病风险的剂量效应更新分析
基于丹麦乳腺癌协作组1977—2005年数据,531例放疗后发生缺血性心脏病者与1069例对照匹配,其中196例病例和413例对照可精确剂量估算。切线光子放疗者平均心脏剂量每增加1 Gy,主要冠脉事件超额比值比线性增加19%(95%CI 1%–63%,p=0.02);电子束技术者无显著关联。
要点
- 切线光子放疗者平均心脏剂量每1 Gy主要冠脉事件超额比值比增加19%(95%CI 1%–63%,p=0.02)。
- 左侧切线放疗平均心脏剂量中位数2.41 Gy,右侧0.68 Gy。
- 电子束技术者平均心脏剂量与主要冠脉事件风险无显著关联(K=-0.05,95%CI -12%–9%,p=1.00)。
核心结论
- 基于个体剂量估算,平均心脏剂量每增加1 Gy主要冠脉事件超额比值比增加19%,高于既往报告。
研究设计与样本
- 从丹麦乳腺癌协作组数据库识别1977—2005年早期乳腺癌放疗后发生缺血性心脏病者531例,匹配无心脏病对照1069例。
- 196例病例和413例对照接受切线光子技术,具备精确剂量估算数据。
主要发现
- 切线放疗者平均心脏剂量中位数左侧2.41 Gy、右侧0.68 Gy。
- 病例平均心脏剂量高于对照(0.84 Gy对0.71 Gy,p<0.001)。
- 切线光子放疗者K=19%(95%CI 1%–63%,p=0.02)。
- 电子束技术者K=-0.05(95%CI -12%–9%,p=1.00),无显著关联。
临床怎么用
- 乳腺癌放疗计划评估心脏剂量时,应关注平均心脏剂量与主要冠脉事件的线性剂量效应关系。
局限性
- 精确剂量估算仅覆盖部分病例和对照(196例病例、413例对照),且限于切线光子技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The increase in the risk of heart disease from incidental exposure of the heart during radiotherapy for breast cancer has been estimated previously from retrospective data in Danish and Swedish women. Here we present an analysis of the Danish material updated with new cases and controls, extended follow-up period, and with refined dose estimates using simulator films or CT data. MATERIAL AND METHODS: From the database of the Danish Breast Cancer Cooperative Group, we identified 531 women diagnosed with early-stage breast cancer from 1977 to 2005, who developed subsequent ischemic heart disease (cases) and matched them to 1069 controls without heart disease after radiotherapy. Data were available for precise dose estimation for 196 cases and 413 controls receiving tangential photon techniques. RESULTS: The median of the mean heart doses for the women receiving tangential radiotherapy was 2.41 Gy for left- and 0.68 Gy for right-sided radiotherapy. The mean heart dose was higher for cases than controls (0.84 Gy and 0.71 Gy, respectively; p < 0.001). In this group, the linear increase in the excess odds ratio of major coronary events per gray of mean heart dose (K) was 19 percent (95% Confidence Interval(CI) 1% to 63%, p = 0.02). For patients treated with electron techniques, there was no significant association between mean heart dose and the risk of major coronary events (K = -0.05, 95% CI -12% to 9%, p = 1.00). CONCLUSION: The increase in the excess odds of major coronary events per gray mean heart dose using individual dose estimates is higher than previously reported.
引用
- Laugaard Lorenzen E, Christian Rehammar J, Jensen MB, et al. Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977-2005. Radiother Oncol. 2020. PMID: 32858067. doi:10.1016/j.radonc.2020.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。